Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Owley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CNS Spectrums|April 21, 2004
The pharmacological treatment of autistic spectrum disordersThomas Owley
Journal of Child and Adolescent Psychopharmacology|May 25, 2005
EPS or stereotypies?Thomas Owley, Bennett Leventhal, Edwin H Cook
Journal of Child and Adolescent Psychopharmacology|August 22, 2002
Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorderThomas Owley, Soyna Owley, Bennett Leventhal, et al.
CNS Spectrums|March 6, 2004
Impact of recent findings on study design of future autism clinical trialsEric Hollander, Ann Phillips, Bryan H King, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2005
An open-label trial of escitalopram in pervasive developmental disordersThomas Owley, Laura Walton, Jeff Salt, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disordersThomas Owley, Jeff Salt, Stephen Guter, et al.
Pharmacogenetics and Genomics|August 28, 2015
Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorderJeffrey R Bishop, Fedra Najjar, Leah H Rubin, et al.
Autism Research : Official Journal of the International Society for Autism Research|December 19, 2009
A pharmacogenetic study of escitalopram in autism spectrum disordersThomas Owley, Camille W Brune, Jeff Salt, et al.
Journal of Autism and Developmental Disorders|January 30, 2003
Utility of the Gilliam Autism Rating Scale in research and clinical populationsMikle South, Brenda J Williams, William M McMahon, et al.
Journal of Child and Adolescent Psychopharmacology|August 12, 2015
Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in AutismFedra Najjar, Thomas Owley, Matthew W Mosconi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS Spectrums|April 21, 2004
The pharmacological treatment of autistic spectrum disordersThomas Owley
Journal of Child and Adolescent Psychopharmacology|May 25, 2005
EPS or stereotypies?Thomas Owley, Bennett Leventhal, Edwin H Cook
Journal of Child and Adolescent Psychopharmacology|August 22, 2002
Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorderThomas Owley, Soyna Owley, Bennett Leventhal, et al.
CNS Spectrums|March 6, 2004
Impact of recent findings on study design of future autism clinical trialsEric Hollander, Ann Phillips, Bryan H King, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2005
An open-label trial of escitalopram in pervasive developmental disordersThomas Owley, Laura Walton, Jeff Salt, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disordersThomas Owley, Jeff Salt, Stephen Guter, et al.
Pharmacogenetics and Genomics|August 28, 2015
Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorderJeffrey R Bishop, Fedra Najjar, Leah H Rubin, et al.
Autism Research : Official Journal of the International Society for Autism Research|December 19, 2009
A pharmacogenetic study of escitalopram in autism spectrum disordersThomas Owley, Camille W Brune, Jeff Salt, et al.
Journal of Autism and Developmental Disorders|January 30, 2003
Utility of the Gilliam Autism Rating Scale in research and clinical populationsMikle South, Brenda J Williams, William M McMahon, et al.
Journal of Child and Adolescent Psychopharmacology|August 12, 2015
Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in AutismFedra Najjar, Thomas Owley, Matthew W Mosconi, et al.
Pageof 2